Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inner Mongolia Kingdomway Pharmaceutical is a major subsidiary of the Xiamen Kingdomway Group, specializing in the large-scale production of high-value nutritional and pharmaceutical ingredients. The company is one of the world's leading manufacturers of Coenzyme Q10 (CoQ10), utilizing advanced fermentation technologies to supply global markets. In addition to CoQ10, the company produces Vitamin A, Vitamin D3, and Nicotinamide Mononucleotide (NMN), positioning itself as a critical player in the anti-aging and metabolic health sectors. Its facilities in Inner Mongolia are designed for high-capacity industrial fermentation and chemical synthesis, serving the pharmaceutical, dietary supplement, and animal nutrition industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inner Mongolia Kingdomway.